CLINICAL_TRIALS
withdrawal
· 2026-04-15
Clinical Trial Update: Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's [Phase 1]
Summary
The ClinicalTrials.gov entry shows a Phase 1 trial investigating mesenchymal stem cells for pouch fistulas in Crohn's disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Crohn's Disease, Fistula | Phase 1 | Status: WITHDRAWN